Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.26 | 0.07 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.07 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.3 | 0.07 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.07 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.087 | 0.07 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.07 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.07 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.07 |